In clinical trials, DUPIXENT reduced nasal congestion and nasal polyp size in patients with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP), and improved the ability to smell.

In clinical studies, utilizing a symptom measurement tool, people taking DUPIXENT saw an improved ability to smell in as little as 3 days. Learn more about these trials and how DUPIXENT may help treat your symptoms

Discover the results